Table 2.
Unadjusted PR | 95% CI | P-value | Adjusted PR a |
95% CI | P-value | |
---|---|---|---|---|---|---|
Demographics | ||||||
Sex | ||||||
Male | Ref. | Ref. | ||||
Female | 1.84 | 1.01-3.38 | .049 | 2.19 | 1.07-4.49 | .030 |
Age (years) | ||||||
40-49 | Ref. | Ref. | ||||
50-59 | 1.01 | 0.53-1.89 | .997 | 1.24 | 0.58-2.68 | .580 |
≥60 | 1.16 | 0.51-2.64 | .717 | 1.58 | 0.66-3.78 | .308 |
Educational level (years) | ||||||
≥12 | Ref. | NA | ||||
<12 | 1.61 | 0.91-2.86 | .105 | |||
Current employment type | ||||||
Employed | Ref. | NA | ||||
Retired | 2.36 | 1.15-4.82 | .019 | |||
Unemployed | 1.49 | 0.76-2.89 | .242 | |||
Civil status | ||||||
Single | Ref. | NA | ||||
Married or domestic partnership | 0.71 | 0.36-1.38 | .313 | |||
Social factors | ||||||
Alcohol use | ||||||
No | Ref. | Ref. | ||||
Yes | 1.30 | 0.70-2.21 | .466 | 0.96 | 0.47-1.94 | .898 |
Current smoker | ||||||
No | Ref. | Ref. | ||||
Yes | 1.92 | 1.06-3.45 | .030 | 2.25 | 1.15-4.43 | .018 |
HIV characteristics | ||||||
Year of HIV diagnosis | 1.02 | 0.98-1.06 | .438 | 0.96 | 0.89-1.03 | .209 |
CD4 count | ||||||
<500 copies/mL | Ref. | Ref. | ||||
≥500 copies/mL | 1.80 | 0.90-3.57 | .099 | 1.69 | 0.82-3.50 | .155 |
Plasma HIV viral load | ||||||
Undetectable | Ref. | Ref. | ||||
Detectable | 1.22 | 0.54-2.76 | .628 | 1.76 | 0.66-4.70 | .258 |
Prior non-CNS opportunistic infection b | ||||||
No | Ref. | Ref. | ||||
Yes | 1.73 | 0.98-3.05 | .057 | 2.24 | 1.05-4.76 | .037 |
Efavirenz, current use | ||||||
No | Ref. | Ref. | ||||
Yes | 0.63 | 0.36-1.11 | .115 | 0.38 | 0.16-090 | .027 |
Adherence to ART | ||||||
No | Ref. | Ref. | ||||
Yes | 0.55 | 0.31-0.99 | .050 | 0.79 | 0.36-1.72 | .547 |
Multivariable analyses were adjusted for the following covariates: sex, age, current alcohol use, current smoker, years with HIV diagnosis, current absolute CD4 count, plasma HIV viral load, prior opportunistic infection, current efavirenz use, adherence to ART.
Prior opportunistic infection included any history of: candidiasis, Kaposi's sarcoma, cytomegalovirus, or pneumocystis pneumonia.
Abbreviations: 95% CI, 95% confidence interval; ART, antiretroviral treatment; CNS, central nervous system; PR, prevalence ratio; Ref., reference; SD, standard deviation.
Bold text, P < .05 (significant).